Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2)

References

• Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635–646.
   PubMed Web of Science ®Google Scholar
• van Saase JL, Van Romunde LK, Cats A, et al. Epidemiology of osteoarthritis: zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis. 1989;48:271–280.
   PubMed Web of Science ®Google Scholar
• Mikkelsen WM, Dodge HJ, Duff IF, et al. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959-60. J Chronic Dis. 1967;20:351–369.
   PubMedGoogle Scholar
• Dieppe P. Research in osteoarthritis. Curr Opin Rheumatol. 2006;18:512–513.
   PubMed Web of Science ®Google Scholar
• Loughlin J. Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting. Curr Opin Rheumatol. 2005;17:629–633.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Chen Y, et al. UFL1 attenuates IL-1β-induced inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol. 2020;81:106278.
   PubMed Web of Science ®Google Scholar
• Fei J, Liang B, Jiang C, et al. Luteolin inhibits IL-1β-induced infiammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586–1592.
   PubMed Web of Science ®Google Scholar
• Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis - chondrocytes in focus. Cell Signal. 2019;53:212–223.
   PubMed Web of Science ®Google Scholar
• Liao CR, Wang SN, Zhu SY, et al. Advanced oxidation protein products increase TNF-α and IL-1β expression in chondrocytes via NADPH oxidase 4 and accelerate cartilage degeneration in osteoarthritis progression. Redox Biol. 2020;28:101306.
   PubMed Web of Science ®Google Scholar
• Wang BW, Jiang Y, Yao ZL, et al. Aucubin protects chondrocytes against IL-1β-induced apoptosis in vitro and inhibits osteoarthritis in mice model. Drug Des Devel Ther. 2019;13:3529–3538.
   PubMed Web of Science ®Google Scholar
• Calapai G, Casciaro M, Miroddi M, et al. Montelukast-induced adverse drug reactions: a review of case reports in the literature. Pharmacology. 2014;94:60–70.
   PubMed Web of Science ®Google Scholar
• Montelukast. In: editors. LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD); 2012.
   Google Scholar
• Back M, Yin L, Nagy E, et al. The leukotriene receptor antagonist montelukast and aortic stenosis. Br J Clin Pharmacol. 2013;75:280–281.
   PubMed Web of Science ®Google Scholar
• Lataifeh AR, Deas S, Shalin SC, et al. A 62-year-old women with persistent severe asthma, skin rash, and eosinophilia. Chest. 2014;146:e52–e55.
   PubMed Web of Science ®Google Scholar
• Dong H, Liu F, Ma F, et al. Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol. 2018;61:215–221.
   PubMed Web of Science ®Google Scholar
• Mohamadin AM, Elberry AA, Elkablawy MA, et al. Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology. 2011;18:235–242.
   PubMedGoogle Scholar
• Song W, Zhang Y, Wang J, et al. Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes. Cytokine. 2018;103:83–89.
   PubMed Web of Science ®Google Scholar
• Kang JH, Lim H, Lee DS, et al. Montelukast inhibits RANKLinduced osteoclast formation and bone loss via CysLTR1 and P2Y12. Mol Med Rep. 2018;18:2387–2398.
   PubMed Web of Science ®Google Scholar
• Elswefy SE, Abdallah FR, Atteia HH, et al. Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A-induced liver fibrosis in male rats. Int J Exp Pathol. 2016;97:369–379.
   PubMed Web of Science ®Google Scholar
• Long H, Li Q, Xiao Z, et al. LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway. Bioengineered. 2021;12:3148–3158.
   PubMed Web of Science ®Google Scholar
• Shi J, Cao F, Chang Y, et al. Long non-coding RNA MCM3AP-AS1 protects chondrocytes ATDC5 and CHON-001 from IL-1β-induced inflammation via regulating miR-138-5p/SIRT1. Bioengineered. 2021;12:1445–1456.
   PubMed Web of Science ®Google Scholar
• Tang Y, Li Y, Xin D, et al. Icariin alleviates osteoarthritis by regulating autophagy of chondrocytes by mediating PI3K/AKT/mTOR signaling. Bioengineered. 2021;12:2984–2999.
   PubMed Web of Science ®Google Scholar
• Thomas CM, Fuller CJ, Whittles CE, et al. Chondrocyte death by apoptosis is associated with the initiation and severity of articular cartilage degradation. Int J Rheum Dis. 2011;14:191–198.
   PubMed Web of Science ®Google Scholar
• Chien SY, Tsai CH, Liu SC, et al. Noggin inhibits IL-1β and BMP-2 expression, and attenuates cartilage degeneration and subchondral bone destruction in experimental osteoarthritis. Cells. 2020;9. DOI:10.3390/cells9040927
   Web of Science ®Google Scholar
• Chunlei H, Chang Z, Sheng L, et al. Down-regulation of MiR-138-5p protects chondrocytes ATDC5 and CHON-001 from IL-1 β-induced inflammation via up-regulating SOX9. Curr Pharm Des. 2020;25:4613–4621.
   PubMed Web of Science ®Google Scholar
• Xie P, Dan F, Yu G, et al. Laquinimod mitigated IL-1β-induced impairment of the cartilage extracellular matrix in human ATDC5 chondrocytes. Chem Res Toxicol. 2020;33:933–939.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Di X, Tang X, Di X. Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: an implication for the treatment of atherosclerosis. Biochem Biophys Res Commun. 2017;486:58–62.
   PubMed Web of Science ®Google Scholar
• Gao X, Jiang S, Du Z, et al. KLF2 protects against osteoarthritis by repressing oxidative response through activation of Nrf2/ARE signaling in vitro and in vivo. Oxid Med Cell Longev. 2019;2019:8564681.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang Q, Gao Z, et al. Baicalin alleviates IL-1β-induced inflammatory injury via down-regulating miR-126 in chondrocytes. Biomed Pharmacother. 2018;99:184–190.
   PubMed Web of Science ®Google Scholar
• Mathieu JR, Heinis M, Zumerle S, et al. Investigating the real role of HIF-1 and HIF-2 in iron recycling by macrophages. Haematologica. 2014;99:e112–114.
   PubMed Web of Science ®Google Scholar
• Turpaev KT. Transcription factor KLF2 and its role in the regulation of inflammatory processes. Biochemistry (Mosc). 2020;85:54–67.
   PubMed Web of Science ®Google Scholar
• Novodvorsky P, Chico TJ. The role of the transcription factor KLF2 in vascular development and disease. Prog Mol Biol Transl Sci. 2014;124:155–188.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhou LR, Wang XS, et al. KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1. Biochem Biophys Res Commun. 2018;495:20–26.
   PubMed Web of Science ®Google Scholar